Annual EBITDA
-$421.95 M
-$352.77 M-509.94%
December 31, 2023
Summary
- As of February 8, 2025, SLRN annual EBITDA is -$421.95 million, with the most recent change of -$352.77 million (-509.94%) on December 31, 2023.
- During the last 3 years, SLRN annual EBITDA has fallen by -$380.15 million (-909.59%).
- SLRN annual EBITDA is now -909.59% below its all-time high of -$41.79 million, reached on December 31, 2021.
Performance
SLRN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$43.83 M
+$49.08 M+52.82%
September 30, 2024
Summary
- As of February 8, 2025, SLRN quarterly EBITDA is -$43.83 million, with the most recent change of +$49.08 million (+52.82%) on September 30, 2024.
- Over the past year, SLRN quarterly EBITDA has increased by +$61.23 million (+58.28%).
- SLRN quarterly EBITDA is now -194.45% below its all-time high of -$14.89 million, reached on June 1, 2022.
Performance
SLRN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$324.52 M
+$50.55 M+13.48%
September 30, 2024
Summary
- As of February 8, 2025, SLRN TTM EBITDA is -$324.52 million, with the most recent change of +$50.55 million (+13.48%) on September 30, 2024.
- Over the past year, SLRN TTM EBITDA has increased by +$97.42 million (+23.09%).
- SLRN TTM EBITDA is now -1917.56% below its all-time high of -$16.09 million, reached on March 1, 2022.
Performance
SLRN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SLRN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -509.9% | +58.3% | +23.1% |
| 3 y3 years | -909.6% | +75.6% | -39.3% |
| 5 y5 years | -909.6% | +75.6% | -39.3% |
SLRN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -909.6% | at low | -194.4% | +75.6% | -1917.6% | +23.1% |
| 5 y | 5-year | -909.6% | at low | -194.4% | +75.6% | -1917.6% | +23.1% |
| alltime | all time | -909.6% | at low | -194.4% | +75.6% | -1917.6% | +23.1% |
Acelyrin EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$43.83 M(-52.8%) | -$324.52 M(-13.5%) |
| Jun 2024 | - | -$92.91 M(+12.3%) | -$375.07 M(+15.5%) |
| Mar 2024 | - | -$82.72 M(-21.3%) | -$324.83 M(-23.0%) |
| Dec 2023 | -$421.95 M | -$105.06 M(+11.3%) | -$421.95 M(+24.2%) |
| Sep 2023 | - | -$94.38 M(+121.2%) | -$339.70 M(+30.3%) |
| Jun 2023 | - | -$42.67 M(-76.3%) | -$260.71 M(+11.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$179.83 M(+688.3%) | -$232.93 M(+236.7%) |
| Dec 2022 | -$69.18 M(+65.5%) | -$22.81 M(+48.2%) | -$69.18 M(+49.2%) |
| Sep 2022 | - | -$15.40 M(+3.4%) | -$46.37 M(+49.7%) |
| Jun 2022 | - | -$14.89 M(-7.5%) | -$30.97 M(+92.5%) |
| Mar 2022 | - | -$16.09 M | -$16.09 M |
| Dec 2021 | -$41.79 M | - | - |
FAQ
- What is Acelyrin annual EBITDA?
- What is the all time high annual EBITDA for Acelyrin?
- What is Acelyrin annual EBITDA year-on-year change?
- What is Acelyrin quarterly EBITDA?
- What is the all time high quarterly EBITDA for Acelyrin?
- What is Acelyrin quarterly EBITDA year-on-year change?
- What is Acelyrin TTM EBITDA?
- What is the all time high TTM EBITDA for Acelyrin?
- What is Acelyrin TTM EBITDA year-on-year change?
What is Acelyrin annual EBITDA?
The current annual EBITDA of SLRN is -$421.95 M
What is the all time high annual EBITDA for Acelyrin?
Acelyrin all-time high annual EBITDA is -$41.79 M
What is Acelyrin annual EBITDA year-on-year change?
Over the past year, SLRN annual EBITDA has changed by -$352.77 M (-509.94%)
What is Acelyrin quarterly EBITDA?
The current quarterly EBITDA of SLRN is -$43.83 M
What is the all time high quarterly EBITDA for Acelyrin?
Acelyrin all-time high quarterly EBITDA is -$14.89 M
What is Acelyrin quarterly EBITDA year-on-year change?
Over the past year, SLRN quarterly EBITDA has changed by +$61.23 M (+58.28%)
What is Acelyrin TTM EBITDA?
The current TTM EBITDA of SLRN is -$324.52 M
What is the all time high TTM EBITDA for Acelyrin?
Acelyrin all-time high TTM EBITDA is -$16.09 M
What is Acelyrin TTM EBITDA year-on-year change?
Over the past year, SLRN TTM EBITDA has changed by +$97.42 M (+23.09%)